Lamas Eugenia, Salinas Rodrigo, Vuillaume Dominique
INSERM, U 1142, LIMICS, F-75006, Paris, France.
Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Stud Health Technol Inform. 2016;221:36-40.
A characteristic feature of the development of health-related social networks is the emergence of internet-based virtual communities, composed of patients. These communities go beyond the mere interchange of information concerning their conditions, intervening in the planning and execution of clinical research, including randomised controlled trials, in collaboration with health professionals. That was the case, in 2009, when patients suffering amyotrophic lateral sclerosis, a rare and severe disease, conducted a clinical trial in USA, organising themselves through an online platform. This initiative launched a new model for the planning and conduction of clinical research: "Participants-Led Research" (PLR). The distinctive particularities of this new research paradigm represent a challenge to the traditional standards used for judging the ethical soundness of clinical investigation. That is the case, for example, of informed consent. This article aims at identifying the ethical, legal, and social issues (ELSI) posed by PLR and the relevant concepts that may help in solving them. The following issues, in particular, are analysed, that may give place to a new social contract for the ethical assessment of clinical research: consent for participating in research and personal integrity; data protection and confidentiality; benefits sharing and intellectual property.
与健康相关的社交网络发展的一个显著特征是基于互联网的虚拟社区的出现,这些社区由患者组成。这些社区不仅仅是交流有关他们病情的信息,还与健康专业人员合作,参与临床研究的规划和实施,包括随机对照试验。2009年,患有肌萎缩侧索硬化症(一种罕见且严重的疾病)的患者通过一个在线平台自行组织在美国进行了一项临床试验,就是这样一个例子。这一举措开创了一种临床研究规划和实施的新模式:“参与者主导的研究”(PLR)。这种新研究范式的独特特性对用于判断临床研究伦理合理性的传统标准构成了挑战。例如,知情同意就是这种情况。本文旨在确定PLR带来的伦理、法律和社会问题(ELSI)以及可能有助于解决这些问题的相关概念。特别分析了以下可能导致临床研究伦理评估新社会契约的问题:参与研究的同意和个人完整性;数据保护和保密;利益分享和知识产权。